FDA Hires Consultants To Ease Conflicts Between CDER Staff
FDA is bringing in outside consultants to help improve staff interactions and build leadership in the agency's Center for Drug Evaluation and Research
You may also be interested in...
There may be more at stake for FDA, and the pharmaceutical industry in general, in how the advisory committees interpret the RECORD trial than there is for Avandia itself.
Bioethecist R. Alta Charo Comes To FDA After Stints On IoM Drug Safety Group, NIH Embryo Research Panel
University of Wisconsin professor of law and bioethics will join FDA as a senior advisor.
FDA should explain the why of its important regulatory decisions in consumer-friendly language, according to the Pharmaceutical Research and Manufacturers of America